[Cov19, seroprevalence studies and Individuals Protection Committees: aren't the technological and organizational challenges enough ?].
- DOI
- 10.1016/j.pharma.2020.04.001
- Published
- 2020 Jul
- Container
- Annales pharmaceutiques francaises
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.pharma.2020.04.001,
title = {[Cov19, seroprevalence studies and Individuals Protection Committees: aren't the technological and organizational challenges enough ?].},
author = {Huriet C and Megerlin F},
year = {2020},
journal = {Annales pharmaceutiques francaises},
doi = {10.1016/j.pharma.2020.04.001},
url = {https://doi.org/10.1016/j.pharma.2020.04.001}
}RIS
TY - JOUR TI - [Cov19, seroprevalence studies and Individuals Protection Committees: aren't the technological and organizational challenges enough ?]. AU - Huriet C AU - Megerlin F PY - 2020 JO - Annales pharmaceutiques francaises DO - 10.1016/j.pharma.2020.04.001 UR - https://doi.org/10.1016/j.pharma.2020.04.001 ER -
APA
C, H., & F, M. (2020). [Cov19, seroprevalence studies and Individuals Protection Committees: aren't the technological and organizational challenges enough ?].. Annales pharmaceutiques francaises. https://doi.org/10.1016/j.pharma.2020.04.001
Source records
- pubmed · retrieved 2026-09-27T08:34:43.876Z
- europe-pmc · retrieved 2026-09-27T08:34:43.872Z